Adherence to guidelines for the prescription of secondary prevention medication at hospital discharge after acute coronary syndrome: A multicentre study

Netherlands Heart Journal

Volumn 23, Issue 4, 2015, Pages 214-221

  Tra, J ^a   van der Wulp, I ^a   Appelman, Y ^a   de Bruijne, M C ^a   Wagner, C ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Acute coronary syndrome; Acute coronary syndrome drug therapy; Guideline adherence; Patient discharge; Quality indicators; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PURINERGIC P2Y12 RECEPTOR;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; ARTICLE; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; DATA ANALYSIS SOFTWARE; DATA PROCESSING; DIABETES MELLITUS; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFORMATION PROCESSING; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRESCRIPTION; SECONDARY PREVENTION; SENSITIVITY ANALYSIS; SMOKING; UNIVARIATE ANALYSIS; UNSTABLE ANGINA PECTORIS;

EID: 84961291989     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-015-0664-y     Document Type: Article

References (27)

1. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297:1892-900.
2. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727-2733.
3. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909-2945.
4. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999-3054.
5. Bauer T, Gitt AK, Junger C, et al. Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence. Eur J Cardiovasc Prev Rehabil. 2010;17:576-581.
6. Kotseva K, Wood D, De Backer G, De Bacquer D. Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey. Eur J Prev Cardiol. 2013;20:817-826.
7. Chew DP, Huynh LT, Liew D, Astley C, Soman A, Brieger D. Potential survival gains in the treatment of myocardial infarction. Heart. 2009;95:1844-1850.
8. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295:1912-1920.
9. Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305:1677-1684.
10. VMS veiligheidsprogramma [VMS safety management program]. Optimale zorg bij acute coronaire syndromen [Optimal care for acute coronary syndromes]. 2010. http://www.vmszorg.nl/.
11. Tra J, Engel J, van der Wulp I, de Bruijne MC, Wagner C. Monitoring guideline adherence in the management of acute coronary syndrome in hospitals: design of a multicentre study. Neth Heart J. 2014;22:346-353.
12. Dutch Health Insurance Counsil. Pharmacotherapeutic Compass. 2012. http://www.fk.cvz.nl/.
13. Little RA. Test of missing completely at random for multivariate data with missing values. J Am Stat Assoc. 1988;83:1198-1202.
14. Rubin D. Inference and missing data. Biometrika. 1976;63:581-592.
15. Yetgin T, van der Linden MM, de Vries AG, et al. Current discharge management of acute coronary syndromes: data from the Rijnmond Collective Cardiology Research (CCR) study. Neth Heart J. 2014;22:20-27.
16. Pedone C, Di Pasquale G, Greco C, et al. Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study. Acute Card Care. 2009;11:222-228.
17. Savarese G, Costanzo P, Cleland JG, et al. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure. J Am Coll Cardiol. 2013;61:131-142.
18. Austin PC, Tu JV, Alter DA. Comparing hierarchical modeling with traditional logistic regression analysis among patients hospitalized with acute myocardial infarction: should we be analyzing cardiovascular outcomes data differently? Am Heart J. 2003;145:27-35.
19. Somma KA, Bhatt DL, Fonarow GC, et al. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012;5:654-661.
20. McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011;124:40-47.
21. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent STsegment elevation. Eur Heart J. 2002;23:1809-1840.
22. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569-2619.
23. Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;6:Cd000259.
24. Forsetlund L, Bjorndal A, Rashidian A, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2009;2:Cd003030.
25. Liem SS, van der Hoeven BL, Oemrawsingh PV, et al. MISSION!: optimization of acute and chronic care for patients with acute myocardial infarction. Am Heart J. 2007;153:14.e1-e11.
26. Arnold SV, Spertus JA, Masoudi FA, et al. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction. J Am Coll Cardiol. 2013;62:1791-801.
27. Margulis AV, Choudhry NK, Dormuth CR, Schneeweiss S. Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004. Pharmacoepidemiol Drug Saf. 2011;20:1088-1097.